Dawn Eringis

Dawn is responsible for initiating and developing commercial partnerships for Integral Molecular. She brings over 25 years of biotechnology and pharmaceutical industry experience, encompassing major pharmaceutical to start-up biotechnology companies. Her career has spanned positions in business development, strategic planning, commercialization, marketing, and product management. She has led or been directly involved in over $500 million of corporate licensing deals in the healthcare industry, including both in-licensing and out-licensing of preclinical assets.

Dawn previously co-founded and served as VP of Business Development and Scientific Affairs for the biotechnology company PolyMedix and co-founded and served as Director of Business Development for Locus Pharmaceuticals. She holds an MBA from the Wharton School of Business, and a B.S. in Chemical Engineering from the University of Pennsylvania.